FDA's proposal to use timelines similar to its framework for sunscreen ingredient time and extent application reviews for evaluations of other drug ingredients proposed for OTC monographs points out that the agency is not changing its standards for approving monograph changes.
While setting deadlines for multiple steps in its reviews of TEAs for OTC ingredients should make the monograph process more transparent to the drug industry, establishing timelines for sunscreen ingredient...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?